Medication Safety

UCSF launches prescription help

The Business Journal: “The UCSF School of Pharmacy has launched a new service in Fresno to address the urgent need among Central Valley residents and their health care providers for assistance in managing their prescriptions. The service will start scheduling appointments this week and will officially open for in-person patient consultations on Sept. 1. Through the program, […]

Posted in | | Leave a response

EMRs as a tool for patient safety.

A short jaunt over to the EMR and HIPPA weblog led me to an interesting article in Time written by Scott Haig, MD. While Dr. Haig touches on a couple of positive features of electronic medical records (EMRs), he like many physicians, focuses on the negatives. He concludes that “Doctors and patients live in a […]

Posted in | | Leave a response

Tablet recognition for safe dispensing…why not?

I recently spied a Twitter post regarding a “pill geometry” database. The idea of a database that houses the geometry of prescription tablets piqued my interest and sent my brain into overdrive. I don’t think that was the intention of the Twitter post, but it jump started by brain nonetheless.

Posted in , | | 2 Responses

Pharmacists aren’t completely worthless after all.

An article in the most recent issue of Archives of Internal Medicine reports the results of adding a pharmacist to a health care team to offer up expertise on appropriate use of medication in heart failure and hypertension. The results showed a 35% reduction in adverse drug events, a 48% reduction in preventable adverse drug […]

Posted in | | 3 Responses

Digital Medicine Article in Business Week

A Business Week article this week took a look at the current state of electronic medical records (EMRs) and technology in healthcare. The author managed to deliver a mixed message without clearly differentiating between electronic medical records and patient safety issues. The article clearly focuses on the negative.

Posted in | | 4 Responses

FDA revises ceftriaxone-calcium warning

The FDA has issued an update to the previous alert on the interaction between calcium and ceftriaxone (Rocephin). The original warning was based on reported fatalities involving neonates. The update occurred after Roche (manufacturer of ceftriaxone) conducted two studies using neonatal and adult plasma with varying concentrations of ceftriaxone and calcium. Based on the results, […]

Posted in | | Leave a response